{"title":"Role of Serum Calcium and Magnesium Estimation at 20-28 Weeks of Gestation in Prediction of Pregnancy-Induced Hypertension.","authors":"Avya Sinha, Zeba Khanam, Anita Rani, Divya Pandey, Monika Gupta, Jyotsna Suri","doi":"10.1007/s13224-025-02217-2","DOIUrl":"https://doi.org/10.1007/s13224-025-02217-2","url":null,"abstract":"<p><strong>Introduction: </strong>Pregnancy-induced hypertension (PIH), a major contributor to global maternal morbidity and mortality, is a disorder marked by elevated blood pressure with or without end-organ damage. It is a condition unique to pregnancy that stems from abnormal uteroplacental development, and possibly, altered mineral homeostasis.</p><p><strong>Objective: </strong>To determine whether estimating serum calcium (Ca<sup>2+</sup>) and magnesium (Mg<sup>2+</sup>) levels in the late-second trimester can predict PIH later in pregnancy.</p><p><strong>Material and methods: </strong>In this prospective cohort study, 225 normotensive gravid women underwent total serum Ca<sup>2+</sup> and Mg<sup>2+</sup> estimations between 20 and 28 weeks of gestation and at delivery. They were followed up until 48 h after delivery for the development of PIH (preeclampsia, gestational hypertension, eclampsia).</p><p><strong>Results: </strong>A total of 52 (23.11%) women developed PIH, of which 14 (6.22%) women had preeclampsia. Although mean (SD) (mg/dL) serum Ca<sup>2+</sup> (8.79(0.38) vs. 8.78(0.38); <i>p</i> = 0.696) and Mg<sup>2+</sup> (1.92(0.25) vs. 1.92(0.21); <i>p</i> = 0.669) levels decreased between the second trimester and delivery, levels remained consistently higher in women with PIH. The ROC-AUC of serum Mg<sup>2+</sup> for predicting PIH and preeclampsia at 20-28 weeks of gestation was 0.577 (95%CI 0.509,0.642); <i>p</i> = 0.09) and 0.647 (95%CI 0.581,0.709; <i>p</i> = 0.041), respectively; for serum Ca<sup>2+</sup>, the values were 0.544 (95%CI 0.476,0.61; <i>p</i> = 0.359) and 0.558 (95%CI 0.491,0.62; <i>p</i> = 0.46), respectively. At a serum Mg<sup>2+</sup>(mg/dL) cut-off value of > 1.9, the sensitivity of predicting preeclampsia was 92.96%, with a NPV value of 98.3%.</p><p><strong>Conclusion: </strong>Total serum Ca<sup>2+</sup> and Mg<sup>2+</sup> levels decrease from the second to third trimesters of pregnancy. A total serum Mg<sup>2+</sup> level of > 1.9 mg/dL at 20-28 weeks of gestation is a relatively inexpensive screening tool that can fairly predict preeclampsia later in pregnancy.</p>","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"76 5","pages":"418-428"},"PeriodicalIF":0.5,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13759881/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149412847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Unseen Risk: Acute Optic Nerve Perineuritis and Vision Loss During Pregnancy-A Case Report and Literature Review.","authors":"Dinesh Choudhary, Manisha Jhirwal, Charu Sharma, Manjari Tandon, Sarbesh Tiwari, Shashank Shekhar","doi":"10.1007/s13224-025-02169-7","DOIUrl":"https://doi.org/10.1007/s13224-025-02169-7","url":null,"abstract":"<p><strong>Background: </strong>Optic perineuritis (OPN) is a rare inflammatory disorder affecting the optic nerve sheath, often mistaken for optic neuritis. Its occurrence during pregnancy is exceptionally rare and poses diagnostic and therapeutic dilemmas due to limited imaging options and concern for fetal safety.</p><p><strong>Case presentation: </strong>A 26-year-old primigravida, 28 weeks and 6 days pregnant, experienced sudden bilateral vision loss that progressed to complete blindness within 24 hours. Ophthalmic evaluation showed signs of Vogt-Koyanagi-Harada (VKH) syndrome, but MRI confirmed bilateral optic nerve perineuritis. The patient was treated with intravenous methylprednisolone and oral corticosteroids. She partially regained her vision and delivered a healthy term infant. Long-term follow-up revealed permanent vision loss in one eye, with some restoration in the other.</p><p><strong>Conclusions: </strong>This case highlights the importance of early recognition and differentiation of optic nerve perineuritis from other causes of vision loss during pregnancy, including VKH syndrome. Prompt diagnosis, multidisciplinary care, and judicious corticosteroid use are crucial for optimizing maternal visual outcomes and fetal safety.</p>","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"76 5","pages":"456-459"},"PeriodicalIF":0.5,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13759889/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149412853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"AGE is just a Number: MARC-Modified Microflare GnRH Agonist Protocol Shows Equal Effectiveness Across POSEIDON Groups 3 and 4.","authors":"Pooja Adiga, Anjali Mundkur, Vidyashree G Poojari, Prashanth Adiga, Pratap Kumar, Shubha Rao, Rashmi Ullagaddi","doi":"10.1007/s13224-025-02257-8","DOIUrl":"https://doi.org/10.1007/s13224-025-02257-8","url":null,"abstract":"<p><strong>Background: </strong>Poor ovarian reserve is a challenge in IVF cycles. How to get the optimum response for a given stimulation protocol is always a question that needs to be answered.</p><p><strong>Purpose of the study: </strong>This study investigates the efficacy of the MARC-modified microflare-up Gonadotropin Releasing Hormone (GnRH) agonist protocol in POSEIDON group 3 and group 4, focusing on its impact on various indices of ovarian response and pregnancy outcomes. Despite the challenges presented by poor ovarian reserve (POR), our research evaluates whether this protocol can deliver consistent results irrespective of age, antral follicle count (AFC), or anti-Müllerian hormone (AMH) levels, Using metrics such as the Follicular Output Rate (FORT), Follicle-to-Oocyte Index (FOI), and Oocyte Sensitivity Index (OSI), we compared outcomes between the two groups.</p><p><strong>Methods: </strong>Women with an Anti-Müllerian Hormone (AMH) ≤ 1.5 ng/mL or an Antral Follicle Count (AFC) ≤ 5 were recruited for the MARC-modified microflare protocol. Modification of the standard micro flare protocol was by avoiding the pre-treatment COC. Eight patients were excluded from the analysis due to cycle cancellation (11.7%) resulting from nonresponse to stimulation. The remaining 60 patients were included for evaluation and grouped into four according to POSEIDON criteria.</p><p><strong>Results: </strong>Eight of the 68 women enrolled were excluded due to cycle cancellation, resulting in a final analysis of 60 women, with 28 in Group A (POSEIDON 3) and 32 in Group B (POSEIDON 4).FORT, FOI, and OSI in both groups were comparable, suggesting the effectiveness of the stimulation protocol. Importantly, the study highlights that age is not a limiting factor in the effectiveness of the MARC-modified microflare protocol. The protocol consistently facilitated a favorable ovarian response regardless of age, AFC, or AMH levels. Key measures, including biochemical and clinical pregnancy rates, showed no significant differences, demonstrating the protocol's uniform effectiveness.</p><p><strong>Conclusion: </strong>MARC-modified microflare-up GnRH agonist protocol proves to be an effective and versatile option for ovarian stimulation in POR patients. Delivering consistent outcomes across varied patient profiles offers a robust solution for managing POR, reinforcing the notion that age is merely a number in the context of ovarian stimulation efficacy in POSEIDON groups 3 and 4.</p>","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"76 5","pages":"410-417"},"PeriodicalIF":0.5,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13759766/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149412837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Comment on \"Risk Scoring in Pregnancy and Maternal and Perinatal Outcomes: A Prospective Observational Study from a Tertiary Care Institute in South India\".","authors":"Eda Güner Özen","doi":"10.1007/s13224-026-02391-x","DOIUrl":"https://doi.org/10.1007/s13224-026-02391-x","url":null,"abstract":"","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"76 5","pages":"462-463"},"PeriodicalIF":0.5,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13760001/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149412842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Evaluation of Clinical Outcomes of Treatment with Botulinum Toxin A Compared to Drug Therapy in Patients with Urge Incontinence: A Clinical Trial Study.","authors":"Zinat Ghanbari, Tahereh Eftekhar, Maryam Deldar, Razie Vahdani, Fedye Haghollahi, Arash Ashouri, Fatemeh Hosseini Salkisari","doi":"10.1007/s13224-025-02242-1","DOIUrl":"https://doi.org/10.1007/s13224-025-02242-1","url":null,"abstract":"<p><strong>Background: </strong>Urge incontinence is one of the disorders that affect many individuals. Treatment of patients is based on drug strategies; however, complete recovery has not been established. The use of botulinum toxin A is an important therapeutic approach that is used alongside other treatments today; however, few studies have been conducted.</p><p><strong>Methods: </strong>Sixty patients participated in this study. Patients are divided into three groups of 20 people. One group was treated with Botox (200 IU), the second with Botox (300 IU), and the third with antimuscarinic drugs. Patients were followed up for 6 months. At the end of 6 months of treatment, the results were evaluated by visiting the patient or calling them and asking the questions of the ICIQ-OAB questionnaire.</p><p><strong>Results: </strong>The percentage of changes in the number of urinations at night in the second group was higher compared to the other two groups; it was statistically significant (<i>p</i> = 0.018). Based on the results, it was shown that no complications were observed in the patients of the both groups. On the contrary, it was shown that in the second group, complications were observed in 4 patients (20%) (<i>p</i> = 0.03).</p><p><strong>Conclusion: </strong>In general, it can be said that treatment with Botox (200 IU) can have a better effect on improving the frequency of urination compared to the other two types of treatment.</p>","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"76 5","pages":"393-400"},"PeriodicalIF":0.5,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13759925/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149412844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"An Observational Study to Determine the Maternal and Fetal Outcomes in Multifetal Pregnancies at an Urban Tertiary Care Centre.","authors":"Shreya Kampoowale, Pradnya Changede, Niranjan Chavan, Arun Nayak","doi":"10.1007/s13224-025-02274-7","DOIUrl":"https://doi.org/10.1007/s13224-025-02274-7","url":null,"abstract":"<p><strong>Introduction: </strong>Multifetal pregnancy is a high-risk pregnancy and a challenge for obstetricians globally. This observational study aims to determine the demographic data of mothers with multifetal pregnancies, the outcomes during the antenatal period, labor and postnatal period, the fetal complications in multifetal pregnancies, and the mode of delivery in these cases.</p><p><strong>Methodology: </strong>A prospective observational, monocentric study was done at Lokmanya Tilak Municipal Medical College and General Hospital, Mumbai.104 patients with multifetal pregnancy who had either aborted or delivered in our tertiary care centre during the study period of 18 months (all patients with multifetal pregnancy-registered/ unregistered/ referred and irrespective of the pregnancy outcome [abortus, livebirth or stillbirth] were included). Demographic factors, Obstetric history and treatment history were recorded; gestational age at delivery, and high-risk factors were noted. Mode of delivery and indication of LSCS were noted from the labor case records. Details of the maternal and neonatal complications in the antenatal period or during the hospital stay were obtained from the indoor papers.</p><p><strong>Results: </strong>Among the 104 cases, 97 (93.26%) were spontaneous conception, 2 cases (1.94%) were through IVF, 4 cases (3.8%) with ovulation induction and 1 case (1%) was through ovulation induction and intrauterine insemination (OV + IUI). The study included 103 twins and 1 (0.96%) triplet pregnancy. Out of the twin gestations, 94 cases (90.39%) were dichorionic diamniotic, 7 cases (6.73%) were monochorionic diamniotic twins, 2 cases (1.92%) were monochorionic monoamniotic, and no case of conjoined twins was found. Preterm delivery was observed in 82 patients (78.8%) while 22 cases (21.2%) were term at delivery. Maximum cases(78 cases) delivered between 28 and 37 weeks (75%) of gestation. 11 cases (10.6%) delivered < 28 weeks of gestation while only 15 cases (14.4%) delivered > 37 weeks gestation at the time of delivery. Mode of delivery was emergency LSCS in 58 cases (55.85%), vaginal delivery for both babies in 35 cases (33.65%), elective LSCS in 4 cases (3.8%), and instrumental delivery in 2 cases (1.9%). Emergency LSCS for the second twin was done in 5 cases (4.80%). Most common indication of Cesarean section in our study was fetal distress. The most common presentation in our study was cephalic- cephalic 63 (60.6%) followed by cephalic breech 19 (18.3%). This study also included the maternal complications in multifetal pregnancies, the most common antenatal complication encountered was anemia (27.88%). 17 cases (16.34%) had PPROM whereas 12 cases (11.53%) had hypothyroidism. Non-cephalic presentation was seen in 11 cases (10.57%).Only 26 babies were transferred to the mother (12.44%) while the rest 169 (80.86%) were admitted in NICU. 14 IUFDs (6.70%) and 7 neonatal deaths (3.34%) were noted.</p><p><strong>Conclusion: </stron","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"76 5","pages":"445-452"},"PeriodicalIF":0.5,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13759888/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149412838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Anemia Eradication in India: What are We Missing?","authors":"Manju Puri, Swati Agrawal, Aparna K Sharma, Rohini Sehgal, Kanika Chopra","doi":"10.1007/s13224-025-02270-x","DOIUrl":"https://doi.org/10.1007/s13224-025-02270-x","url":null,"abstract":"<p><p>India first needs to work on raising the health status of its HCWs before It can bring about a positive change in the health of the general population.</p>","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"76 5","pages":"460-461"},"PeriodicalIF":0.5,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13759752/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149412840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Carcinoma of Endometrium with Special Reference to Molecular and Genetic Aspects.","authors":"Bhagyalaxmi Nayak, S K Giri","doi":"10.1007/s13224-026-02372-0","DOIUrl":"https://doi.org/10.1007/s13224-026-02372-0","url":null,"abstract":"<p><p>Carcinoma of the endometrium is common in elderly. Traditionally classified into Type I and Type II tumors based on clinicopathological features, endometrial carcinoma is now increasingly understood as a biologically heterogeneous disease driven by distinct molecular and genetic alterations. This evolving understanding has transformed diagnostic, prognostic, and therapeutic approaches. This mini-review aims to provide a concise overview of carcinoma of the endometrium, with special emphasis on its molecular and genetic landscape. Key molecular pathways implicated in endometrial carcinogenesis include alterations in PTEN, PIK3CA, KRAS, ARID1A, TP53, POLE, and mismatch repair genes, each contributing to tumor initiation, progression, and clinical behavior. The landmark genomic classification proposed by The Cancer Genome Atlas has redefined endometrial carcinoma into four molecular subgroups: POLE ultramutated, microsatellite instability hypermutated, copy-number low, and copy-number high tumors. These subgroups provide superior prognostic stratification compared to conventional histology alone. The review also highlights the clinical relevance of molecular testing in contemporary practice, including risk assessment, individualized treatment planning, and the emerging role of targeted therapies and immunotherapy. Genetic syndromes such as Lynch syndrome further underscore the importance of hereditary evaluation in selected patients. Incorporation of molecular profiling into standard care pathways has paved the way for precision oncology in endometrial cancer. By integrating traditional pathological concepts with modern genomic insights, this review underscores the paradigm shift in understanding endometrial carcinoma and emphasizes the need for broader adoption of molecular classification to improve patient outcomes and guide future research.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at https://doi.org/10.1007/s13224-026-02372-0.</p>","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"76 5","pages":"376-381"},"PeriodicalIF":0.5,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13759909/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149412841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Recurrent Vulvo-Inguinal Cellular Angiofibroma with Malignant Transformation: A Rare Clinicopathological Entity.","authors":"Gaurav Das, Shalini Shree Krishnamurthy, Kanuj Malik, Shirley Sunder Singh, Anand Raja","doi":"10.1007/s13224-025-02180-y","DOIUrl":"https://doi.org/10.1007/s13224-025-02180-y","url":null,"abstract":"<p><p>Cellular angiofibroma is a benign mesenchymal tumour which occurs mostly in the vulvo-vaginal and inguinoscrotal regions. It is treated by surgical excision, and recurrence is extremely rare. Sarcomatous transformation is rarer still. We report a case of cellular angiofibroma in the vulvo-inguinal region with multiple recurrences and sarcomatous transformation, and discuss about the paucity of available literature for clinical decision-making.</p>","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"76 5","pages":"453-455"},"PeriodicalIF":0.5,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13759875/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149412846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Unlocking Power of Medical Research.","authors":"Sujata Dalvi","doi":"10.1007/s13224-026-02458-9","DOIUrl":"https://doi.org/10.1007/s13224-026-02458-9","url":null,"abstract":"<p><p>The Indian Council of Medical Research (ICMR), New Delhi, convened a half-day symposium on July 22, 2026, with the theme \"Medical Publishing in the Era of AI and Anti-Science - Navigating Challenges, Fostering Integrity.\" The program included keynote addresses and three panel discussions featuring editors, publishers, and journalists.</p>","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"76 5","pages":"371-375"},"PeriodicalIF":0.5,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13759961/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149412848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}